2024-05-19
2024-02-08
November 21, 2024
Summary | |
---|---|
Cancer Type | Lung Cancer |
Grade | NA |
Stage | NA |
Ethnicity | Western |
Gender | F |
Age | 69 |
Pathology Diagnosis | Adenocarcinoma of the Lung. pT2b, N1, M0, R0. |
Biopsy Site | NA |
Treatment History | None |
Pathology QC | Moderately to poorly differentiated adenocarcinoma (P2, P13) |
Special Features | MET and MYC amplified |
Mouse Strain | Balb/c nu, MF-1 nu |
TMA | TMA-HP-LU-015 |
Viral Status in PDX | NA |
Available In | CB_CN, CB-UK |
RNA Seq | P2 |
Exome Seq | P7 |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy